We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

72 hedge funds and large institutions have $418M invested in Mirum Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

420% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 5

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

92% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 12

41% more funds holding

Funds holding: 51 → 72 (+21)

17% more capital invested

Capital invested by funds: $357M → $418M (+$60.8M)

7.42% more ownership

Funds ownership: 73.79% → 81.21% (+7.4%)

Holders
72
Holders Change
+21
Holders Change %
+41.18%
% of All Funds
1.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
26
Increased
23
Reduced
12
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$9.73M
2
DCM
Driehaus Capital Management
Illinois
+$8.54M
3
RSCM
Rock Springs Capital Management
Maryland
+$3.32M
4
BCM
Burrage Capital Management
Massachusetts
+$3.18M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.9M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.07M
2
Two Sigma Investments
Two Sigma Investments
New York
-$743K
3
WVP
Worth Venture Partners
New Jersey
-$677K
4
Goldman Sachs
Goldman Sachs
New York
-$442K
5
Citadel Advisors
Citadel Advisors
Florida
-$225K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
26
Verition Fund Management
Connecticut
$1.7M +$1.91M +97,066 New
State Street
27
State Street
Massachusetts
$1.66M -$153K -7,785 -8%
Morgan Stanley
28
Morgan Stanley
New York
$1.57M +$823K +41,848 +87%
Wellington Management Group
29
Wellington Management Group
Massachusetts
$1.49M +$1.68M +85,400 New
Deutsche Bank
30
Deutsche Bank
Germany
$1.25M +$1.36M +69,135 +2,614%
CIP
31
Chartwell Investment Partners
Pennsylvania
$1.21M +$464K +23,625 +52%
PM
32
Prosight Management
Texas
$1.05M +$1.18M +60,250 New
Charles Schwab
33
Charles Schwab
California
$1.04M +$21K +1,066 +2%
AA
34
ALPS Advisors
Colorado
$802K +$903K +45,910 New
Invesco
35
Invesco
Georgia
$785K +$180K +9,143 +26%
Renaissance Technologies
36
Renaissance Technologies
New York
$749K +$843K +42,900 New
LCM
37
Laurion Capital Management
New York
$730K +$822K +41,800 New
CCM
38
CAAS Capital Management
New York
$635K +$715K +36,362 New
RJA
39
Raymond James & Associates
Florida
$582K +$655K +33,333 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$481K +$160K +8,142 +42%
Tudor Investment Corp
41
Tudor Investment Corp
Connecticut
$437K +$491K +25,000 New
N
42
Nuveen
North Carolina
$433K -$2.65K -135 -0.5%
Two Sigma Advisers
43
Two Sigma Advisers
New York
$403K +$454K +23,100 New
GCP
44
GSA Capital Partners
United Kingdom
$379K +$427K +21,709 New
Squarepoint
45
Squarepoint
New York
$374K -$43.6K -2,220 -9%
PAM
46
Panagora Asset Management
Massachusetts
$370K +$416K +21,169 New
Wells Fargo
47
Wells Fargo
California
$332K +$270K +13,752 +260%
WVP
48
Worth Venture Partners
New Jersey
$287K -$677K -34,456 -68%
Citadel Advisors
49
Citadel Advisors
Florida
$269K -$225K -11,442 -43%
Two Sigma Investments
50
Two Sigma Investments
New York
$262K -$743K -37,783 -72%
1
2
3 4

MIRM Hedge Fund Activity: Q4 2020 in Review

72 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q4 2020, worth a combined $418M — up 17% from $357M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new MIRM positions and 5 closed out — a net gain of 21 holders — while 23 added to existing stakes and 12 trimmed.

The largest buyer was Sio Capital Management, opening a new position worth an estimated $9.73M. The largest seller was Fidelity Investments, cutting an estimated $1.07M.

  • 72 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q4 2020, up from 51 in Q3 2020.
  • Funds reported $418M of Mirum Pharmaceuticals stock for Q4 2020, up 17% quarter-over-quarter.
  • 26 funds opened new Mirum Pharmaceuticals positions in Q4 2020 and 5 closed out, a net change of +21 holders.
  • The largest Mirum Pharmaceuticals buyer in Q4 2020 was Sio Capital Management, an estimated $9.73M added.
  • The largest Mirum Pharmaceuticals seller in Q4 2020 was Fidelity Investments, an estimated $1.07M sold.

Based on aggregated 13F filings for Q4 2020.